Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Morris

Showing results (1321-1330 of 5,069) with videos related to

Pageof 507
Sort By:
European Journal of Pharmacology|August 5, 1983
Temperature-sensitive reversible loss of [3H]imipramine binding sites: evidence suggesting different conformational statesA Dumbrille-Ross, J Morris, A Davis, et al.
Animal Blood Groups and Biochemical Genetics|January 1, 1982
Sheep lymphocyte antigens: a preliminary studyP R Cullen, C Bunch, J Brownlie, et al.
Lancet (London, England)|April 5, 1980
Isocyanate-induced asthma in a car factoryW G White, M J Morris, E Sugden, et al.
Immunogenetics|January 1, 1983
A monoclonal antibody recognizing HLA-DR2 on malignant and activated cellsS V Fuggle, J Kirkley, A Ting, et al.
Human Pathology|July 1, 1992
Utility of immunohistochemistry in distinguishing ovarian sertoli-stromal cell tumors from carcinosarcomasM J Costa, R J Morris, R Wilson, et al.
American Journal of Hypertension|July 6, 2004
No association of angiotensin-converting enzyme 2 gene (ACE2) polymorphisms with essential hypertensionAdam V Benjafield, William Y S Wang, Brian J Morris
ANZ Journal of Surgery|April 21, 2005
Staphylococcal post-sternotomy mediastinitis: five year auditArlo Upton, Sally A Roberts, Paget Milsom, et al.
Heart and Vessels|February 13, 1999
Forearm vascular responses during semierect dynamic leg exercise in patients following myocardial infarctionH Thomson, J Morris-Thurgood, J Atherton, et al.
DNA and Cell Biology|March 1, 1991
Prolactin-deficient GH3B3 cells are defective in the utilization of the endogenous prolactin promoter yet are fully competent to initiate transcription from a transfected prolactin promoterT E Arnold, I K Farrance, J Morris, et al.
Nature Reviews. Clinical Oncology|March 6, 2013
Validation and clinical utility of prostate cancer biomarkersHoward I Scher, Michael J Morris, Steven Larson, et al.
Pageof 507

Showing results (1321-1330 of 5,069) with videos related to

Sort By:
Pageof 507
European Journal of Pharmacology|August 5, 1983
Temperature-sensitive reversible loss of [3H]imipramine binding sites: evidence suggesting different conformational statesA Dumbrille-Ross, J Morris, A Davis, et al.
Animal Blood Groups and Biochemical Genetics|January 1, 1982
Sheep lymphocyte antigens: a preliminary studyP R Cullen, C Bunch, J Brownlie, et al.
Lancet (London, England)|April 5, 1980
Isocyanate-induced asthma in a car factoryW G White, M J Morris, E Sugden, et al.
Immunogenetics|January 1, 1983
A monoclonal antibody recognizing HLA-DR2 on malignant and activated cellsS V Fuggle, J Kirkley, A Ting, et al.
Human Pathology|July 1, 1992
Utility of immunohistochemistry in distinguishing ovarian sertoli-stromal cell tumors from carcinosarcomasM J Costa, R J Morris, R Wilson, et al.
American Journal of Hypertension|July 6, 2004
No association of angiotensin-converting enzyme 2 gene (ACE2) polymorphisms with essential hypertensionAdam V Benjafield, William Y S Wang, Brian J Morris
ANZ Journal of Surgery|April 21, 2005
Staphylococcal post-sternotomy mediastinitis: five year auditArlo Upton, Sally A Roberts, Paget Milsom, et al.
Heart and Vessels|February 13, 1999
Forearm vascular responses during semierect dynamic leg exercise in patients following myocardial infarctionH Thomson, J Morris-Thurgood, J Atherton, et al.
DNA and Cell Biology|March 1, 1991
Prolactin-deficient GH3B3 cells are defective in the utilization of the endogenous prolactin promoter yet are fully competent to initiate transcription from a transfected prolactin promoterT E Arnold, I K Farrance, J Morris, et al.
Nature Reviews. Clinical Oncology|March 6, 2013
Validation and clinical utility of prostate cancer biomarkersHoward I Scher, Michael J Morris, Steven Larson, et al.
Pageof 507